| 000 | 01153 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250514010159.0 | ||
| 264 | 0 | _c20010927 | |
| 008 | 200109s 0 0 eng d | ||
| 022 | _a0264-410X | ||
| 024 | 7 |
_a10.1016/s0264-410x(01)00205-5 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCartwright, K | |
| 245 | 0 | 0 |
_aMeningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria, 6-8 October, 2000. _h[electronic resource] |
| 260 |
_bVaccine _cAug 2001 |
||
| 300 |
_a4347-56 p. _bdigital |
||
| 500 | _aPublication Type: Congress | ||
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aEurope _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMeningococcal Infections _xepidemiology |
| 650 | 0 | 4 |
_aMeningococcal Vaccines _xtherapeutic use |
| 650 | 0 | 4 |
_aNeisseria meningitidis _ximmunology |
| 650 | 0 | 4 |
_aVaccines, Conjugate _xtherapeutic use |
| 700 | 1 | _aNoah, N | |
| 700 | 1 | _aPeltola, H | |
| 773 | 0 |
_tVaccine _gvol. 19 _gno. 31 _gp. 4347-56 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0264-410x(01)00205-5 _zAvailable from publisher's website |
| 999 |
_c11458265 _d11458265 |
||